{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:18:08Z","timestamp":1780708688768,"version":"3.54.1"},"reference-count":157,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":2767,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3945\/an.113.005264","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T13:21:42Z","timestamp":1405344102000},"page":"394-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Supplemental Substances Derived from Foods as Adjunctive Therapeutic Agents for Treatment of Neurodegenerative Diseases and Disorders"],"prefix":"10.1016","volume":"5","author":[{"given":"Gregory E.","family":"Bigford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Del Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/an.113.005264_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1009068804787","article-title":"Traumatic brain injury as a risk factor for Alzheimer's disease: a review","volume":"10","author":"Lye","year":"2000","journal-title":"Neuropsychol Rev"},{"key":"10.3945\/an.113.005264_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","article-title":"Chronic neuropathologies of single and repetitive TBI: substrates of dementia?","volume":"9","author":"Smith","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3945\/an.113.005264_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nurt.2009.10.023","article-title":"Cell death mechanisms and modulation in traumatic brain injury","volume":"7","author":"Stoica","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.3945\/an.113.005264_bib4","doi-asserted-by":"crossref","first-page":"12795","DOI":"10.1523\/JNEUROSCI.3520-09.2009","article-title":"Nutrition, brain aging, and neurodegeneration","volume":"29","author":"Joseph","year":"2009","journal-title":"J Neurosci"},{"key":"10.3945\/an.113.005264_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08983","article-title":"Neural mechanisms of ageing and cognitive decline","volume":"464","author":"Bishop","year":"2010","journal-title":"Nature"},{"key":"10.3945\/an.113.005264_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.neubiorev.2012.02.013","article-title":"Traumatic brain injury: a risk factor for Alzheimer's disease","volume":"36","author":"Sivanandam","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3945\/an.113.005264_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"issue":"Suppl 1","key":"10.3945\/an.113.005264_bib8","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ypmed.2011.01.023","article-title":"The combined effects of exercise and foods in preventing neurological and cognitive disorders","volume":"52","author":"Gomez-Pinilla","year":"2011","journal-title":"Prev Med"},{"key":"10.3945\/an.113.005264_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1254\/jphs.10R33FM","article-title":"Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease","volume":"116","author":"Hashimoto","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.3945\/an.113.005264_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog Lipid Res"},{"key":"10.3945\/an.113.005264_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MOG.0b013e3283505a3b","article-title":"Carnitine derivatives: clinical usefulness","volume":"28","author":"Malaguarnera","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.3945\/an.113.005264_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-9422(02)00513-7","article-title":"Rosmarinic acid","volume":"62","author":"Petersen","year":"2003","journal-title":"Phytochemistry"},{"key":"10.3945\/an.113.005264_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0091-3057(03)00122-9","article-title":"Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers","volume":"75","author":"Tildesley","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3945\/an.113.005264_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.physbeh.2004.09.010","article-title":"Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers","volume":"83","author":"Tildesley","year":"2005","journal-title":"Physiol Behav"},{"key":"10.3945\/an.113.005264_bib15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881110385594","article-title":"Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults","volume":"25","author":"Kennedy","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.3945\/an.113.005264_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00213-008-1101-3","article-title":"An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers","volume":"198","author":"Scholey","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3945\/an.113.005264_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2710.2003.00463.x","article-title":"Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial","volume":"28","author":"Akhondzadeh","year":"2003","journal-title":"J Clin Pharm Ther"},{"key":"10.3945\/an.113.005264_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-3057(03)00108-4","article-title":"Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial","volume":"75","author":"Perry","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3945\/an.113.005264_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1211\/0022357001774598","article-title":"In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes","volume":"52","author":"Perry","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"10.3945\/an.113.005264_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0091-3057(03)00125-4","article-title":"Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil","volume":"75","author":"Savelev","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3945\/an.113.005264_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ptr.1451","article-title":"Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents","volume":"18","author":"Savelev","year":"2004","journal-title":"Phytother Res"},{"key":"10.3945\/an.113.005264_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tox.2008.06.010","article-title":"Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis","volume":"250","author":"Lee","year":"2008","journal-title":"Toxicology"},{"key":"10.3945\/an.113.005264_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ptr.904","article-title":"Peroxynitrite scavenging activity of herb extracts","volume":"16","author":"Choi","year":"2002","journal-title":"Phytother Res"},{"key":"10.3945\/an.113.005264_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/10715760500231836","article-title":"Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages","volume":"39","author":"Qiao","year":"2005","journal-title":"Free Radic Res"},{"key":"10.3945\/an.113.005264_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-10-28","article-title":"Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response","volume":"10","author":"Luan","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.3945\/an.113.005264_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: the in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.3945\/an.113.005264_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/mnfr.201100143","article-title":"Resveratrol and health\u2013a comprehensive review of human clinical trials","volume":"55","author":"Smoliga","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.3945\/an.113.005264_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","author":"Jang","year":"1997","journal-title":"Science"},{"key":"10.3945\/an.113.005264_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-9120(96)00155-5","article-title":"Resveratrol: a molecule whose time has come? And gone?","volume":"30","author":"Soleas","year":"1997","journal-title":"Clin Biochem"},{"key":"10.3945\/an.113.005264_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2010.05853.x","article-title":"Clinical trials of resveratrol","volume":"1215","author":"Patel","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.3945\/an.113.005264_bib31","doi-asserted-by":"crossref","first-page":"e19881","DOI":"10.1371\/journal.pone.0019881","article-title":"What is new for an old molecule? Systematic review and recommendations on the use of resveratrol","volume":"6","author":"Vang","year":"2011","journal-title":"PLoS One"},{"key":"10.3945\/an.113.005264_bib32","unstructured":"ClinicalTrials.gov [database on the Internet]. Bethesda (MD). [cited 2014 May 5]. Available from: http:\/\/www.clinicaltrials.gov\/ct2\/results?term=resveratrol"},{"key":"10.3945\/an.113.005264_bib33","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3945\/ajcn.2009.28641","article-title":"Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation","volume":"91","author":"Kennedy","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.113.005264_bib34","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0891-5849(03)00062-5","article-title":"Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death","volume":"34","author":"Jang","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/an.113.005264_bib35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bjp.0705688","article-title":"Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C","volume":"141","author":"Han","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.3945\/an.113.005264_bib36","doi-asserted-by":"crossref","first-page":"40364","DOI":"10.1074\/jbc.M509329200","article-title":"SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3945\/an.113.005264_bib37","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2174\/138161206778793010","article-title":"The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta","volume":"12","author":"Ono","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.3945\/an.113.005264_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J Neurochem"},{"key":"10.3945\/an.113.005264_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.intimp.2004.08.008","article-title":"Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia","volume":"5","author":"Bi","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.3945\/an.113.005264_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2008.04.015","article-title":"Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships","volume":"174","author":"Meng","year":"2008","journal-title":"Chem Biol Interact"},{"key":"10.3945\/an.113.005264_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2010.03.043","article-title":"Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation","volume":"636","author":"Zhang","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.3945\/an.113.005264_bib42","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0024-3205(02)02083-0","article-title":"Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats","volume":"71","author":"Sharma","year":"2002","journal-title":"Life Sci"},{"key":"10.3945\/an.113.005264_bib43","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J"},{"key":"10.3945\/an.113.005264_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochem Int"},{"key":"10.3945\/an.113.005264_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-006-9253-0","article-title":"Neuroprotection by resveratrol against traumatic brain injury in rats","volume":"294","author":"Ates","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.3945\/an.113.005264_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2006.06.096","article-title":"Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus","volume":"1111","author":"Gao","year":"2006","journal-title":"Brain Res"},{"key":"10.3945\/an.113.005264_bib47","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/aje\/kwj267","article-title":"Curry consumption and cognitive function in the elderly","volume":"164","author":"Ng","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.3945\/an.113.005264_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2006.08.018","article-title":"Lower levels of cerebrospinal fluid amyloid beta (Abeta) in non-demented Indian controls","volume":"407","author":"Subramanian","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.3945\/an.113.005264_bib49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2010.06.075","article-title":"Cerebrospinal fluid profile of amyloid beta42 (Abeta42), hTau and ubiquitin in North Indian Alzheimer's disease patients","volume":"487","author":"Kandimalla","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.3945\/an.113.005264_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.3945\/an.113.005264_bib51","doi-asserted-by":"crossref","unstructured":"Ringman J, Cole GM, Tend E, et al, Oral curcumin for the treatment of mild-to-moderate Alzheimer's disease: tolerability and clinical and biomarker efficacy result of a placebo-controlled 24-week study. Proceedings of the International Conference on Alzheimer's Disease, 2008 June 24\u201327; Chicago, IL","DOI":"10.1016\/j.jalz.2008.05.2414"},{"key":"10.3945\/an.113.005264_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6882-6-10","article-title":"Dose escalation of a curcuminoid formulation","volume":"6","author":"Lao","year":"2006","journal-title":"BMC Complement Altern Med"},{"key":"10.3945\/an.113.005264_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"key":"10.3945\/an.113.005264_bib54","doi-asserted-by":"crossref","first-page":"e32616","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"key":"10.3945\/an.113.005264_bib55","doi-asserted-by":"crossref","first-page":"e31869","DOI":"10.1371\/journal.pone.0031869","article-title":"A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization","volume":"7","author":"Orlando","year":"2012","journal-title":"PLoS One"},{"key":"10.3945\/an.113.005264_bib56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/jmf.2006.076","article-title":"Effect of curcumin on intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats","volume":"10","author":"Kumar","year":"2007","journal-title":"J Med Food"},{"key":"10.3945\/an.113.005264_bib57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.euroneuro.2009.02.002","article-title":"Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT)","volume":"19","author":"Ishrat","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3945\/an.113.005264_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2009.09.027","article-title":"Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats","volume":"1301","author":"Reeta","year":"2009","journal-title":"Brain Res"},{"key":"10.3945\/an.113.005264_bib59","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.fct.2008.05.030","article-title":"Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation","volume":"46","author":"Park","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.3945\/an.113.005264_bib60","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J Neurosci"},{"key":"10.3945\/an.113.005264_bib61","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0197-4580(01)00300-1","article-title":"Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology","volume":"22","author":"Frautschy","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.113.005264_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-2327.40220","article-title":"The effect of curcumin (turmeric) on Alzheimer's disease: an overview","volume":"11","author":"Mishra","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"key":"10.3945\/an.113.005264_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.05.022","article-title":"A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Abeta plus ibotenic acid-infused rat model of Alzheimer's disease","volume":"1400","author":"Ahmed","year":"2011","journal-title":"Brain Res"},{"key":"10.3945\/an.113.005264_bib64","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.3945\/an.113.005264_bib65","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s11064-008-9775-9","article-title":"Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity","volume":"33","author":"Calabrese","year":"2008","journal-title":"Neurochem Res"},{"key":"10.3945\/an.113.005264_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.expneurol.2005.09.004","article-title":"Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition","volume":"197","author":"Wu","year":"2006","journal-title":"Exp Neurol"},{"key":"10.3945\/an.113.005264_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2010.08.027","article-title":"A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma","volume":"226","author":"Sharma","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3945\/an.113.005264_bib68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1545968310397706","article-title":"Brain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma","volume":"25","author":"Wu","year":"2011","journal-title":"Neurorehabil Neural Repair"},{"key":"10.3945\/an.113.005264_bib69","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.neuroscience.2009.04.042","article-title":"Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma","volume":"161","author":"Sharma","year":"2009","journal-title":"Neuroscience"},{"key":"10.3945\/an.113.005264_bib70","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1471-4159.2010.06630.x","article-title":"Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?","volume":"113","author":"Laird","year":"2010","journal-title":"J Neurochem"},{"key":"10.3945\/an.113.005264_bib71","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bcp.2008.12.011","article-title":"Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats","volume":"77","author":"Conboy","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.3945\/an.113.005264_bib72","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuroscience.2010.05.078","article-title":"Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease","volume":"169","author":"Ahmed","year":"2010","journal-title":"Neuroscience"},{"key":"10.3945\/an.113.005264_bib73","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/syn.20876","article-title":"Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices","volume":"65","author":"Ahmed","year":"2011","journal-title":"Synapse"},{"key":"10.3945\/an.113.005264_bib74","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3945\/an.113.005264_bib75","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","article-title":"Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model","volume":"102","author":"Garcia-Alloza","year":"2007","journal-title":"J Neurochem"},{"key":"10.3945\/an.113.005264_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNR.0b013e328341e141","article-title":"Tetrahydrocurcumin confers protection against amyloid beta-induced toxicity","volume":"22","author":"Mishra","year":"2011","journal-title":"Neuroreport"},{"issue":"2","key":"10.3945\/an.113.005264_bib77","first-page":"CD003158","article-title":"Acetyl-L-carnitine for dementia","author":"Hudson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3945\/an.113.005264_bib78","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200303000-00001","article-title":"Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease","volume":"18","author":"Montgomery","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.3945\/an.113.005264_bib79","first-page":"131","article-title":"Effects of acetyl-L-carnitine (ALC) treatment in dementia: a mutlicentric, randomized, double-blind study","volume":"3","author":"Battistin","year":"1989","journal-title":"New Trends Clin Neuropharmacol"},{"key":"10.3945\/an.113.005264_bib80","first-page":"17","article-title":"Acetyl-L-carnitine as a therapeutic agent for mental deterioration in geriatric patients. (Double-blind placebo controlled study)","volume":"3","author":"Mantero","year":"1989","journal-title":"New Trends Clin Neuropharmacol"},{"key":"10.3945\/an.113.005264_bib81","first-page":"75","article-title":"Acetyl-L-carnitine in the treatment of mildly demented elderly patients","volume":"10","author":"Passeri","year":"1990","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.3945\/an.113.005264_bib82","first-page":"345","article-title":"Acetyl-l-carnitine activity in senile dementia Alzheimer type","volume":"11","author":"Bellagamba","year":"1991","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.113.005264_bib83","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gps.930061205","article-title":"Acetyl-L-carnitine in dementia","volume":"6","author":"Livingston","year":"1991","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3945\/an.113.005264_bib84","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1212\/WNL.41.11.1726","article-title":"Long-term acetyl-L-carnitine treatment in Alzheimer's disease","volume":"41","author":"Spagnoli","year":"1991","journal-title":"Neurology"},{"key":"10.3945\/an.113.005264_bib85","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/03007995.2020.12102584","article-title":"Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors","volume":"19","author":"Bianchetti","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.3945\/an.113.005264_bib86","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneur.1992.00530350051019","article-title":"Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease","volume":"49","author":"Sano","year":"1992","journal-title":"Arch Neurol"},{"key":"10.3945\/an.113.005264_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002826-199304000-00005","article-title":"Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans","volume":"16","author":"Costa","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.3945\/an.113.005264_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-4580(95)80001-8","article-title":"Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease","volume":"16","author":"Pettegrew","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.113.005264_bib89","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1185\/03007999009112690","article-title":"Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia","volume":"11","author":"Rai","year":"1990","journal-title":"Curr Med Res Opin"},{"key":"10.3945\/an.113.005264_bib90","first-page":"511","article-title":"Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain","volume":"24","author":"Bonavita","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.3945\/an.113.005264_bib91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.47.3.705","article-title":"A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease","volume":"47","author":"Thal","year":"1996","journal-title":"Neurology"},{"key":"10.3945\/an.113.005264_bib92","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.55.6.805","article-title":"A 1-year controlled trial of acetyl-l-carnitine in early-onset AD","volume":"55","author":"Thal","year":"2000","journal-title":"Neurology"},{"key":"10.3945\/an.113.005264_bib93","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1753-4887.1992.tb01306.x","article-title":"Acetyl-carnitine and Alzheimer's disease","volume":"50","author":"Bowman","year":"1992","journal-title":"Nutr Rev"},{"key":"10.3945\/an.113.005264_bib94","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1749-6632.1992.tb38710.x","article-title":"Action of acetyl-L-carnitine in neurodegeneration and Alzheimer's disease","volume":"663","author":"Calvani","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.3945\/an.113.005264_bib95","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1533317508325093","article-title":"Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension","volume":"23","author":"Chan","year":"2008","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3945\/an.113.005264_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","article-title":"Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","volume":"24","author":"Remington","year":"2009","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3945\/an.113.005264_bib97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0197-4580(90)90110-L","article-title":"Acetyl-1-carnitine. 2: Effects on learning and memory performance of aged rats in simple and complex mazes","volume":"11","author":"Barnes","year":"1990","journal-title":"Neurobiol Aging"},{"issue":"Suppl 1","key":"10.3945\/an.113.005264_bib98","first-page":"S99","article-title":"Acetyl-L-carnitine improves aged brain function","volume":"10","author":"Kobayashi","year":"2010","journal-title":"Geriatr Gerontol Int"},{"key":"10.3945\/an.113.005264_bib99","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1196\/annals.1320.010","article-title":"Delaying the mitochondrial decay of aging with acetylcarnitine","volume":"1033","author":"Ames","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.3945\/an.113.005264_bib100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/rej.2009.0955","article-title":"Acetyl-L-carnitine supplementation to old rats partially reverts the age-related mitochondrial decay of soleus muscle by activating peroxisome proliferator-activated receptor gamma coactivator-1alpha-dependent mitochondrial biogenesis","volume":"13","author":"Pesce","year":"2010","journal-title":"Rejuvenation Res"},{"key":"10.3945\/an.113.005264_bib101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01250574","article-title":"Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo","volume":"86","author":"Janiri","year":"1991","journal-title":"J Neural Transm Gen Sect"},{"key":"10.3945\/an.113.005264_bib102","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.3945\/an.113.005264_bib103","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jnr.490370112","article-title":"Neuroprotective activity of acetyl-L-carnitine: studies in vitro","volume":"37","author":"Forloni","year":"1994","journal-title":"J Neurosci Res"},{"key":"10.3945\/an.113.005264_bib104","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jnr.20877","article-title":"Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1\u201342-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"84","author":"Abdul","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.3945\/an.113.005264_bib105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1582-4934.2008.00324.x","article-title":"Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats","volume":"13","author":"Aliev","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.3945\/an.113.005264_bib106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jns.2009.03.002","article-title":"The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease","volume":"283","author":"Shenk","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.3945\/an.113.005264_bib107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nutres.2008.11.004","article-title":"Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance","volume":"29","author":"Suchy","year":"2009","journal-title":"Nutr Res"},{"key":"10.3945\/an.113.005264_bib108","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000323178","article-title":"Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain","volume":"32","author":"Scafidi","year":"2010","journal-title":"Dev Neurosci"},{"key":"10.3945\/an.113.005264_bib109","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12640-010-9165-3","article-title":"Chronic pretreatment with acetyl-L-carnitine and +\/\u2212DL-alpha-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function","volume":"19","author":"Nagesh Babu","year":"2011","journal-title":"Neurotox Res"},{"key":"10.3945\/an.113.005264_bib110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/17460875.2.4.403","article-title":"Role of lipids in brain injury and diseases","volume":"2","author":"Adibhatla","year":"2007","journal-title":"Future Lipidol"},{"key":"10.3945\/an.113.005264_bib111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell Biochem"},{"key":"10.3945\/an.113.005264_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(00)00017-5","article-title":"The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina","volume":"40","author":"Lauritzen","year":"2001","journal-title":"Prog Lipid Res"},{"key":"10.3945\/an.113.005264_bib113","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/ajcn\/77.4.803","article-title":"Cognitive decline and fatty acid composition of erythrocyte membranes\u2013The EVA Study","volume":"77","author":"Heude","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.113.005264_bib114","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ajcn\/85.4.1103","article-title":"Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study","volume":"85","author":"Beydoun","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.113.005264_bib115","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11745-000-0646-3","article-title":"Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment","volume":"35","author":"Conquer","year":"2000","journal-title":"Lipids"},{"key":"10.3945\/an.113.005264_bib116","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3945\/an.113.005264_bib117","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02536067","article-title":"Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease","volume":"26","author":"S\u00f6derberg","year":"1991","journal-title":"Lipids"},{"key":"10.3945\/an.113.005264_bib118","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.60.7.940","article-title":"Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3945\/an.113.005264_bib119","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.WNL.0000103860.75218.A5","article-title":"Dietary intake of fatty acids and fish in relation to cognitive performance at middle age","volume":"62","author":"Kalmijn","year":"2004","journal-title":"Neurology"},{"key":"10.3945\/an.113.005264_bib120","first-page":"381","article-title":"DHA and cognitive function in the elderly: a systematic review of the literature","volume":"11","author":"Noel","year":"2006","journal-title":"Res Pract Alzheimers Dis"},{"key":"10.3945\/an.113.005264_bib121","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.113.005264_bib122","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3945\/an.113.005264_bib123","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci Res"},{"key":"10.3945\/an.113.005264_bib124","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3945\/an.113.005264_bib125","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.3945\/an.113.005264_bib126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.plefa.2009.05.015","article-title":"Omega-3 fatty acids and dementia","volume":"81","author":"Cole","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.113.005264_bib127","first-page":"A393","article-title":"Omega-3 fatty acids and lipoic acid in Alzheimer's disease","volume":"70","author":"Shinto","year":"2008","journal-title":"Neurology"},{"key":"10.3945\/an.113.005264_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2009.10.003","article-title":"Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial","volume":"6","author":"Scheltens","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.113.005264_bib129","series-title":"National Research Council, Trauma and the Brain Committee on Nutrition, Institute of Medicine","article-title":"Nutrition and traumatic brain injury: improving acute and subacute health outcomes in military personnel","author":"Erdman","year":"2011"},{"key":"10.3945\/an.113.005264_bib130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/2152-7806.85987","article-title":"Stuck at the bench: potential natural neuroprotective compounds for concussion","volume":"2","author":"Petraglia","year":"2011","journal-title":"Surg Neurol Int"},{"key":"10.3945\/an.113.005264_bib131","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/neu.2012.2672","article-title":"Omega-3 fatty acids as a putative treatment for traumatic brain injury","volume":"30","author":"Hasadsri","year":"2013","journal-title":"J Neurotrauma"},{"key":"10.3945\/an.113.005264_bib132","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/497273","article-title":"Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia","volume":"41","author":"Wohl","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.3945\/an.113.005264_bib133","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.clinthera.2007.07.018","volume":"29","author":"Davidson","year":"2007","journal-title":"Clin Ther"},{"key":"10.3945\/an.113.005264_bib134","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.plefa.2009.05.004","article-title":"Toxicology and safety of DHA","volume":"81","author":"Lien","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.113.005264_bib135","series-title":"Potential neuroprotective strategies for traumatic brain injury. In: Neurochemical aspects of neurotraumatic and neurodegenerative diseases","author":"Farooqui","year":"2010"},{"key":"10.3945\/an.113.005264_bib136","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","article-title":"Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease","volume":"22","author":"Calon","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.3945\/an.113.005264_bib137","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/acel.12026","article-title":"Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1","volume":"12","author":"Latour","year":"2013","journal-title":"Aging Cell"},{"key":"10.3945\/an.113.005264_bib138","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1471-4159.1999.0721133.x","article-title":"Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats","volume":"72","author":"Hossain","year":"1999","journal-title":"J Neurochem"},{"key":"10.3945\/an.113.005264_bib139","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1471-4159.2002.00905.x","article-title":"Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats","volume":"81","author":"Hashimoto","year":"2002","journal-title":"J Neurochem"},{"key":"10.3945\/an.113.005264_bib140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jn\/135.3.549","article-title":"Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats","volume":"135","author":"Hashimoto","year":"2005","journal-title":"J Nutr"},{"key":"10.3945\/an.113.005264_bib141","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nbd.2006.04.013","article-title":"Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP\/PS1 transgenic mice","volume":"23","author":"Oksman","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.3945\/an.113.005264_bib142","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","article-title":"Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels","volume":"27","author":"Green","year":"2007","journal-title":"J Neurosci"},{"key":"10.3945\/an.113.005264_bib143","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-2011-111010","article-title":"Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease","volume":"27","author":"Lebbadi","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/an.113.005264_bib144","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-2275(20)38713-7","article-title":"Effect of dietary alpha-linolenate\/linoleate balance on brain lipid compositions and learning ability of rats","volume":"28","author":"Yamamoto","year":"1987","journal-title":"J Lipid Res"},{"key":"10.3945\/an.113.005264_bib145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-2760(96)00007-0","article-title":"Correlation between level of (n-3) polyunsaturated fatty acids in brain phospholipids and learning ability in rats. A multiple generation study","volume":"1300","author":"Jensen","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/an.113.005264_bib146","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0047-6374(97)00169-3","article-title":"Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet","volume":"101","author":"Suzuki","year":"1998","journal-title":"Mech Ageing Dev"},{"key":"10.3945\/an.113.005264_bib147","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0306-4522(99)00107-4","article-title":"Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats","volume":"93","author":"Gamoh","year":"1999","journal-title":"Neuroscience"},{"issue":"Suppl","key":"10.3945\/an.113.005264_bib148","first-page":"S239","article-title":"Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks","volume":"34","author":"Greiner","year":"1999","journal-title":"Lipids"},{"key":"10.3945\/an.113.005264_bib149","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1024\/0300-9831.70.5.251","article-title":"Effect of dietary docosahexaenoic acid and phosphatidylcholine on maze behavior and fatty acid composition of plasma and brain lipids in mice","volume":"70","author":"Lim","year":"2000","journal-title":"Int J Vitam Nutr Res"},{"key":"10.3945\/an.113.005264_bib150","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/jn\/130.6.1629","article-title":"Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice","volume":"130","author":"Lim","year":"2000","journal-title":"J Nutr"},{"key":"10.3945\/an.113.005264_bib151","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1440-1681.2001.03437.x","article-title":"Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats","volume":"28","author":"Gamoh","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.3945\/an.113.005264_bib152","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jn\/131.2.319","article-title":"Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain","volume":"131","author":"Lim","year":"2001","journal-title":"J Nutr"},{"key":"10.3945\/an.113.005264_bib153","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/neu.2009.1239","article-title":"Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model","volume":"27","author":"Bailes","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.3945\/an.113.005264_bib154","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1227\/NEU.0b013e3181ff692b","article-title":"Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury","volume":"68","author":"Mills","year":"2011","journal-title":"Neurosurgery"},{"key":"10.3945\/an.113.005264_bib155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3171\/2010.5.JNS08914","article-title":"Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model","volume":"114","author":"Mills","year":"2011","journal-title":"J Neurosurg"},{"key":"10.3945\/an.113.005264_bib156","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1089\/neu.2011.1872","article-title":"The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma","volume":"28","author":"Wu","year":"2011","journal-title":"J Neurotrauma"},{"key":"10.3945\/an.113.005264_bib157","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1753-4887.2010.00307.x","article-title":"Evidence-based criteria in the nutritional context","volume":"68","author":"Blumberg","year":"2010","journal-title":"Nutr Rev"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322012194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322012194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/5\/4\/394\/23738578\/394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:12:33Z","timestamp":1761873153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831322012194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2161831322012194"],"URL":"https:\/\/doi.org\/10.3945\/an.113.005264","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supplemental Substances Derived from Foods as Adjunctive Therapeutic Agents for Treatment of Neurodegenerative Diseases and Disorders","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/an.113.005264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 American Society for Nutrition","name":"copyright","label":"Copyright"}]}}